← Open Payments lookup

SHEILA HENRY: Open Payments

NPI 1639593361 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$550 in 25 payments from 9 companies in 2025. Trend: 2023 $936 · 2024 $1,086 · 2025 $550

Food & beverage: $550
CompanyPaymentsAmount
ABBVIE INC.5$102
Otsuka America Pharmaceutical, Inc.4$87
Teva Pharmaceuticals USA, Inc.4$81
E.R. Squibb & Sons, L.L.C.3$72
Neurocrine BioSciences, Inc.2$63
Vanda Pharmaceuticals Inc.3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$45
Janssen Pharmaceuticals, Inc1$24
Alkermes, Inc.1$19

Products named: VRAYLAR, ABILIFY ASIMTUFII, COBENFY, INGREZZA, UZEDY, CAPLYTA, AUSTEDO XR, FANAPT.

Industry payments across NY — which companies pay providers there.